For healthcare stocks, the election results are the best and the worst of times. Investors perceive the incoming Trump administration as likely to be more friendly toward [insurers’ Medicare ...

Moderna shares advanced after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed its full-year sales forecast. Covid vaccine sales totaled $1.8 ...

Only 13% of children in the U.S. received the 2024-2025 COVID vaccine. The shot was added to the CDC's panel of routine immunizations after ACIP unanimously endorsed its inclusion in 2022.

Approximately one-third (33%) of patients with a long COVID diagnosis recorded at least 90 days after the onset of initial infection met criteria for persistent disease. The incidence of persistent ...

(NewsNation) — New polling from the Economist and YouGov found that 50% of Americans disapprove of Health Secretary Robert F. Kennedy Jr.’s decisions regarding a key vaccine advisory committee. The ...

Harris County shifts $16M from Uplift Harris funds to rental assistance, unhoused initiatives By Melissa Enaje | 3:49 PM Jun 19, 2025 CDT Updated 3:49 PM Jun 19, 2025 CDT ...

The California Senate has introduced a landmark resolution to have the state examine its crude imports from the Amazon, following a visit this week by Indigenous leaders from Ecuador who urged ...

For more information or to sign up for her newsletter, visit her website: pamelabaxterbooks.com. Originally Published: June 19, 2025 at 8:44 AM EDT ...

The number of COVID-19 cases is increasing in parts of the U.S. and worldwide amid the emergency of a sub-variant known as "razor blade throat COVID." The variant — NB.1.8.1. or “Nimbus” – got the ...

An independent investigation into the Seattle Fire Department (SFD) suggested that officials obtained blank vaccine cards and falsely claimed their compliance with Seattle’s COVID-19 vaccine ...

In a webpage dated Jan. 7, 2025, the CDC advises that everyone over the age of six months get the 2024-2025 COVID-19 vaccine, specifically the 2024-2025 Moderna COVID-19 Vaccine.